Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin plus liraglutide in PCOS with insulin resistance
ChiCTR2200057797Phase 4Recruiting
- Sponsor
- Zunyi Medical University Affiliated Hospital
- Start
- Mar 2022
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of metformin and liraglutide in polycystic ovary syndrome (PCOS), sponsored by Zunyi Medical University Affiliated Hospital. Primary endpoint: Glucose metabolic rate (M value). Started Mar 2022; status: recruiting.
02
Drugs
metforminliraglutide
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2200057797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057797.